324 related articles for article (PubMed ID: 15456867)
1. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
[TBL] [Abstract][Full Text] [Related]
2. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.
Dalle S; Imamura T; Rose DW; Worrall DS; Ugi S; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2002 Sep; 22(17):6272-85. PubMed ID: 12167719
[TBL] [Abstract][Full Text] [Related]
3. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
[TBL] [Abstract][Full Text] [Related]
4. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
[TBL] [Abstract][Full Text] [Related]
5. β-Arrestin signal complex plays a critical role in adipose differentiation.
Santos-Zas I; Lodeiro M; Gurriarán-Rodríguez U; Bouzo-Lorenzo M; Mosteiro CS; Casanueva FF; Casabiell X; Pazos Y; Camiña JP
Int J Biochem Cell Biol; 2013 Jul; 45(7):1281-92. PubMed ID: 23557604
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
7. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
Rui L; Fisher TL; Thomas J; White MF
J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.
Zhande R; Mitchell JJ; Wu J; Sun XJ
Mol Cell Biol; 2002 Feb; 22(4):1016-26. PubMed ID: 11809794
[TBL] [Abstract][Full Text] [Related]
9. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
[TBL] [Abstract][Full Text] [Related]
10. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors regulate tyrosine phosphorylation of IRS-1 and insulin signaling in adipocytes.
Rondinone CM; Kramer D
Biochem Biophys Res Commun; 2002 Sep; 296(5):1257-63. PubMed ID: 12207909
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.
Taniyama Y; Hitomi H; Shah A; Alexander RW; Griendling KK
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1142-7. PubMed ID: 15802620
[TBL] [Abstract][Full Text] [Related]
13. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
14. Beta-arrestin and Mdm2, unsuspected partners in signaling from the cell surface.
Strous GJ; Schantl JA
Sci STKE; 2001 Nov; 2001(110):pe41. PubMed ID: 11724970
[TBL] [Abstract][Full Text] [Related]
15. Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2.
Nogués L; Salcedo A; Mayor F; Penela P
J Biol Chem; 2011 Jan; 286(2):1165-73. PubMed ID: 21081496
[TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2.
Wang P; Gao H; Ni Y; Wang B; Wu Y; Ji L; Qin L; Ma L; Pei G
J Biol Chem; 2003 Feb; 278(8):6363-70. PubMed ID: 12488444
[TBL] [Abstract][Full Text] [Related]
17. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.
Sonoda N; Imamura T; Yoshizaki T; Babendure JL; Lu JC; Olefsky JM
Proc Natl Acad Sci U S A; 2008 May; 105(18):6614-9. PubMed ID: 18445652
[TBL] [Abstract][Full Text] [Related]
18. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
Qian H; Pipolo L; Thomas WG
Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
[TBL] [Abstract][Full Text] [Related]
19. GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin.
Yun Y; Yoon HJ; Jeong Y; Choi Y; Jang S; Chung KY; Lee HH
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2301934120. PubMed ID: 37399373
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
